Financhill
Back

Goldman Sachs ActiveBeta® Europe Eq ETF Vs. Neurogene Industry Stock Comparison

Buy
56

GSEU
Goldman Sachs ActiveBeta® Europe Eq ETF

Last Price:
35.21
Seasonality Move:
4.4%
Sell
1

NGNE
Neurogene

Last Price:
34.67
Seasonality Move:
50.43%
Buy
56
Goldman Sachs ActiveBeta® Europe Eq ETF (GSEU) is a Buy

Is Goldman Sachs ActiveBeta® Europe Eq ETF a Buy, Sell or Hold?

  • The current Goldman Sachs ActiveBeta® Europe Eq ETF [GSEU] share price is $35.23. The Score for GSEU is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • GSEU is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
1
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

GSEU Stock Price Chart

What is Goldman Sachs ActiveBeta® Europe Eq ETF's stock price today?

  • The Goldman Sachs ActiveBeta® Europe Eq ETF share price today is $35.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GSEU is experiencing slight selling pressure.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $34.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

GSEU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.56 Sell
Relative Strength Index (14 RSI): 32.24 Sell
Chaikin Money Flow: -2429 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.88 - 37.44) Sell
Bollinger Bands (100): (36.22 - 37.94) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 35.74 Sell
Chaikin Money Flow: -452975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.4 - 61.5) Sell
Bollinger Bands (100): (34.32 - 50.52) Sell

GSEU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.73 Sell
20-day SMA: 36.44 Sell
50-day SMA: 37.26 Sell
200-day SMA: 36.62 Sell
8-day EMA: 35.68 Sell
20-day EMA: 36.29 Sell
50-day EMA: 36.87 Sell
200-day EMA: 36.36 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.3 Sell
20-day SMA: 51.47 Sell
50-day SMA: 46.76 Sell
200-day SMA: 38.99 Sell
8-day EMA: 47.13 Sell
20-day EMA: 50.2 Sell
50-day EMA: 47.47 Sell
200-day EMA: 38.44 Sell

Goldman Sachs ActiveBeta® Europe Eq ETF Earnings Growth & GSEU Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Goldman Sachs ActiveBeta® Europe Eq ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):